Dear MSLP investors.
Please find below the link to MusclePharm (MSLP)’s CEO shareholder letter for 2014. I do believe that the guidance is conservative as for 2013 management had guided for 100mil$ in revenues they will be around 110mil$ instead representing a 65% year over year increase.
For 2014 management is targeting 150mil$ and a profit of 20-22cts per share versus a loss of roughly 1.44$ in 2013.
I continue to hold shares and we should see price appreciation finally and my target of 15$ still holds for this year.